Supplemental Figure 1 from Clinical Utility of a Blood-Based BRAFV600E Mutation Assay in Melanoma
Year: 2023
Type: supplementary-materials
Abstract: BRAFV600E levels in patients with detectable BRAFV600E mutation in tissue who had peripheral blood cell isolation using CPT tubes vs Ficoll.
Authors: David J. Panka, Elizabeth Buchbinder, Anita Giobbie-Hurder, Aislyn P. Schalck, Laleh Montaser-Kouhsari, Alireza Sepehr, Donald P. Lawrence, David F. McDermott, Rachel Cohen, Alexander Carlson, Jennifer A. Wargo, Ryan Merritt, Virginia J. Seery, F. Stephen Hodi, Anasuya Gunturi, Dennie Fredrick, Michael B. Atkins, A. John Iafrate, Keith T. Flaherty, James W. Mier, Ryan J. Sullivan
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362481401